"Muscarinic Agonists" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs that bind to and activate muscarinic cholinergic receptors (RECEPTORS, MUSCARINIC). Muscarinic agonists are most commonly used when it is desirable to increase smooth muscle tone, especially in the GI tract, urinary bladder and the eye. They may also be used to reduce heart rate.
| Descriptor ID |
D018721
|
| MeSH Number(s) |
D27.505.519.625.120.140.500 D27.505.696.577.120.140.500
|
| Concept/Terms |
Muscarinic Agonists- Muscarinic Agonists
- Agonists, Muscarinic
- Muscarinic Agonist
- Agonist, Muscarinic
- Cholinergic Muscarinic Agonists
- Agonists, Cholinergic Muscarinic
- Muscarinic Agonists, Cholinergic
- Cholinergic Agonist, Muscarinic
- Agonist, Muscarinic Cholinergic
- Muscarinic Cholinergic Agonist
- Cholinergic Agonists, Muscarinic
- Agonists, Muscarinic Cholinergic
- Muscarinic Cholinergic Agonists
|
Below are MeSH descriptors whose meaning is more general than "Muscarinic Agonists".
Below are MeSH descriptors whose meaning is more specific than "Muscarinic Agonists".
This graph shows the total number of publications written about "Muscarinic Agonists" by people in this website by year, and whether "Muscarinic Agonists" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 1 | 1 |
| 1997 | 2 | 0 | 2 |
| 1999 | 1 | 1 | 2 |
| 2005 | 1 | 0 | 1 |
| 2006 | 0 | 1 | 1 |
| 2007 | 1 | 1 | 2 |
| 2008 | 0 | 2 | 2 |
| 2009 | 0 | 1 | 1 |
| 2012 | 1 | 0 | 1 |
| 2013 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Muscarinic Agonists" by people in Profiles.
-
Topical bethanechol for the improvement of esophageal dysmotility: a pilot study. Ann Otol Rhinol Laryngol. 2013 Aug; 122(8):481-6.
-
Differential patterns of synaptotagmin7 mRNA expression in rats with kainate- and pilocarpine-induced seizures. PLoS One. 2012; 7(5):e36114.
-
Intensity and duration of chronic ethanol exposure is critical for subsequent escalation of voluntary ethanol drinking in mice. Alcohol Clin Exp Res. 2009 Nov; 33(11):1893-900.
-
Coactivation of M(1) muscarinic and alpha1 adrenergic receptors stimulates extracellular signal-regulated protein kinase and induces long-term depression at CA3-CA1 synapses in rat hippocampus. J Neurosci. 2008 May 14; 28(20):5350-8.
-
Role of M1 receptor in the locomotion behavior of the African mole-rat (Cryptomys sp). J Integr Neurosci. 2008 Mar; 7(1):1-16.
-
A highly efficient method to differentiate smooth muscle cells from human embryonic stem cells. Arterioscler Thromb Vasc Biol. 2007 Dec; 27(12):e311-2.
-
Bethanechol improves smooth muscle function in patients with severe ineffective esophageal motility. J Clin Gastroenterol. 2007 Apr; 41(4):366-70.
-
Coexistence of muscarinic long-term depression with electrically induced long-term potentiation and depression at CA3-CA1 synapses. J Neurophysiol. 2006 Dec; 96(6):3114-21.
-
Pilocarpine treatment of xerostomia induced by psychoactive medications. Am J Psychiatry. 2005 May; 162(5):1023.
-
Presynaptic kappa-opioid and muscarinic receptors inhibit the calcium-dependent component of evoked glutamate release from striatal synaptosomes. J Neurochem. 1999 Sep; 73(3):1058-65.